CASI PHARMACEUTICALS, INC. Impairment of Intangible Assets, Finite-lived
CASI PHARMACEUTICALS, INC. (CASIF) reported Impairment of Intangible Assets, Finite-lived of $696.00 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2026-05-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsFinitelived · last filed 2026-05-15
| Period end | Impairment of Intangible Assets, Finite-lived 12 month |
|---|---|
| 2024-12-31 | $696.00K 20-F · filed 2026-05-15 |
| 2022-12-31 | $8.72M 20-F · filed 2025-03-31 |
| 2020-12-31 | $1.54M 20-F · filed 2023-04-26 |